What are the NCCN guidelines for Anti-CD19 CAR T-cell therapy in the treatment of B-cell follicular lymphoma?

Updated: Feb 23, 2021
  • Author: Mohammad Muhsin Chisti, MD, FACP; Chief Editor: Emmanuel C Besa, MD  more...
  • Print
Answer

Histologic transformation to DLBC

  • Anti-CD19 CAR T-cell therapy (only after 2 prior chemoimmunotherapy regimens)

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!